Cary Denson

Cary Denson has over 15 years of experience in finance roles across various pharmaceutical and healthcare companies. Cary is currently the Vice President of FP&A at Collegium Pharmaceutical, Inc., a position they have held since April 2023. Prior to this, they served as the Senior Director of FP&A at Collegium Pharmaceutical from May 2022 to March 2023. Before joining Collegium Pharmaceutical, Cary worked at AlloVir as a Senior Director of FP&A from October 2020 to April 2022. Cary also held the role of Senior Director and Head of US Neuroscience BU Finance at Takeda from February 2019 to October 2020. At Shire, Cary held multiple roles including Director of US Neuroscience & Established Brands Finance, Associate Director of Global Product Strategy Finance, and Associate Director of Corporate Functions Finance. Cary worked at Shire from April 2015 to February 2019. Earlier in their career, Cary worked at Insulet Corporation as a Manager of FP&A and Senior Financial Analyst, and at Columbia Management and Virtua Research as an Equity Research Associate and Equity Research Analyst respectively. Cary started their professional career as a Finance Intern at Millennium Pharmaceuticals.

Cary Denson holds a Master of Science (M.S.) degree in Finance from the Boston College Carroll School of Management. Prior to this, Cary earned a Bachelor of Business Administration (B.B.A.) degree in Banking and Finance, along with a Bachelor of Arts (B.A.) degree in Mathematics, from Mississippi State University. The specific start and end years for these educational experiences are not provided.